Northcape Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.28M Sell
4,656
-172
-4% -$174K 1.17% 26
2025
Q4
$5.19M Sell
4,828
-2,954
-38% -$2.82M 1.46% 20
2025
Q3
$5.94M Buy
7,782
+79
+1% +$58.8K 1.73% 12
2025
Q2
$6M Buy
7,703
+2,614
+51% +$2.03M 1.83% 12
2025
Q1
$4.2M Sell
5,089
-1,002
-16% -$834K 1.36% 20
2024
Q4
$4.7M Sell
6,091
-20
-0.3% -$16.6K 1.52% 17
2024
Q3
$5.41M Sell
6,111
-1,053
-15% -$947K 1.77% 13
2024
Q2
$6.49M Sell
7,164
-123
-2% -$98.4K 2.34% 9
2024
Q1
$5.67M Hold
7,287
2.07% 11
2023
Q4
$4.25M Sell
7,287
-619
-8% -$361K 1.54% 15
2023
Q3
$4.25M Sell
7,906
-30
-0.4% -$15.5K 1.63% 13
2023
Q2
$3.72M Sell
7,936
-15
-0.2% -$6.29K 1.34% 18
2023
Q1
$2.73M Buy
+7,951
New +$2.68M 0.99% 35
2022
Q4
Sell
-4,362
Closed -$1.41M 105
2022
Q3
$1.41M Buy
4,362
+802
+23% +$254K 0.5% 64
2022
Q2
$1.15M Sell
3,560
-800
-18% -$240K 0.44% 63
2022
Q1
$1.25M Buy
4,360
+800
+22% +$206K 0.36% 72
2021
Q4
$983K Buy
+3,560
New +$902K 0.33% 66

Other funds holding LLY

Northcape Wealth Management's LLY Position: Q1 2026 in Review

Northcape Wealth Management reduced its Eli Lilly (LLY) stake by 3.6% in Q1 2026, selling an estimated $174K and leaving 4,656 shares worth $4.28M. The position accounts for 1.17% of the portfolio, ranked #26.

Northcape Wealth Management first reported a position in LLY in Q4 2021 and has held it in 17 quarters since. The position peaked at $6.49M in Q2 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Northcape Wealth Management held 4,656 shares of Eli Lilly worth $4.28M as of Q1 2026.
  • Northcape Wealth Management sold 172 Eli Lilly shares in Q1 2026, an estimated $174K.
  • Eli Lilly made up 1.17% of Northcape Wealth Management's portfolio in Q1 2026, its #26 holding.
  • Northcape Wealth Management first reported a position in Eli Lilly in Q4 2021 and has held it in 17 quarters since.
  • Northcape Wealth Management's Eli Lilly position peaked at $6.49M in Q2 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Northcape Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.